Cigna Investments Inc. New Raises Position in Welltower Inc. (NYSE:WELL)

Cigna Investments Inc. New increased its holdings in Welltower Inc. (NYSE:WELLFree Report) by 2.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,313 shares of the real estate investment trust’s stock after buying an additional 126 shares during the period. Cigna Investments Inc. New’s holdings in Welltower were worth $795,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in WELL. Livforsakringsbolaget Skandia Omsesidigt increased its stake in Welltower by 320.3% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 4,813 shares of the real estate investment trust’s stock valued at $616,000 after acquiring an additional 3,668 shares during the last quarter. Valeo Financial Advisors LLC increased its stake in Welltower by 2.6% in the third quarter. Valeo Financial Advisors LLC now owns 3,668 shares of the real estate investment trust’s stock valued at $470,000 after acquiring an additional 94 shares during the last quarter. Gateway Investment Advisers LLC bought a new position in Welltower in the third quarter valued at $225,000. Mechanics Bank Trust Department bought a new position in Welltower in the third quarter valued at $211,000. Finally, Sivia Capital Partners LLC bought a new position in shares of Welltower during the third quarter valued at about $219,000. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on WELL. Scotiabank raised their price objective on Welltower from $142.00 to $144.00 and gave the company a “sector outperform” rating in a research note on Monday, January 27th. Bank of America raised their target price on Welltower from $190.00 to $221.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Raymond James raised their target price on Welltower from $145.00 to $155.00 and gave the stock a “strong-buy” rating in a research note on Monday, December 16th. Mizuho raised their target price on Welltower from $136.00 to $141.00 and gave the stock an “outperform” rating in a research note on Thursday, December 5th. Finally, StockNews.com raised Welltower from a “sell” rating to a “hold” rating in a research note on Wednesday, October 30th. Five analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $134.96.

View Our Latest Report on WELL

Welltower Price Performance

Shares of WELL opened at $143.17 on Tuesday. The company has a market capitalization of $89.15 billion, a P/E ratio of 94.19, a price-to-earnings-growth ratio of 2.83 and a beta of 1.23. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a 50 day moving average of $130.34 and a 200 day moving average of $127.79. Welltower Inc. has a twelve month low of $85.40 and a twelve month high of $143.84.

About Welltower

(Free Report)

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.

See Also

Institutional Ownership by Quarter for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.